• AMEND is a co-founding member of the Neuroendocrine Life Alliance (NLA).  NLA is an exciting newly strengthened collaboration between Neuroendocrine Cancer UK and the Association for Multiple Endocrine Neoplasia Disorders (AMEND).

    Watch our video to find out what the NLA is, as well as what it isn’t!

    .

  • About the Neuroendocrine Life Alliance

  • Our two charities have worked together from time-to-time over the years, however; through this enhanced, and more formal, long-term collaboration, we aim to address the following aims for the UK neuroendocrine cancer communities we serve:

    • The delays in time to diagnosis
    • The development and recognition of clear pathways to centres of expertise in the UK
    • Access to and licensing of new treatments and therapies
    • Access to research and clinical trials
    • Supporting patients with the psychological impact of lives, long or short, lives with our neuroendocrine diseases

    Keep an eye on our news and social media channels for more news on the NLA in the future.

    .